Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Preqin: Private real estate fund raising remains low

Monday, February 27, 2012

Bailey McCann, Opalesque New York: Private real estate fundraising improved slightly in the second half of 2011 but still remains significantly below 2007 levels according to new research from global research firm, Preqin. The report is the result of a survey of 180 institutional investors in private real estate funds.

In the report, Real Estate Investor Outlook 2012, Preqin cites investor caution surrounding broader market volatility as the chief cause for stubbornly low fundraising. Along with volatility, investors noted the slower rate of return from real estate investments as well as existing real estate investment commitments as reasons for staying on the sidelines.

North American investors were more active in the space than any other region in the world - with 45% of those surveyed having committed to funds in 2011, compared to 27% of European investors and 25% of Asian investors. Despite that, more than half of respondents said that they had no plans to commit to private real estate funds this year. The current investor appetite for private real estate funds is lower than it has been in two years.

New investments, such that they happen, will likely come from larger investors. These investors will be focused on core and value added strategies. 51% of investors with $10bn or more in total assets are li......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its